Drug makers face sweeping distribution overhaul

Apr 6, 2017
China launches a “Two-Invoice System” to simplify the drug distribution chain and reduce prices and corruption in the healthcare sector. The new policy may bring substantial compliance and business model challenges for pharmaceutical companies
SHARE

Thank you for sharing!

Your article was successfully shared with the contacts you provided.

This premium content is reserved for
China Law & Practice Subscribers.

Benefits Include:

  • Unlimited access to Chinalawandpractice.com site and digital newsletters
  • 5 free articles across the ALM subscription network every 30 days
  • Exclusive discounts on ALM events and publications

Continue reading by getting
started with a subscription.

Subscribe Now For Unlimited Access